Literature DB >> 20335422

USA600 (ST45) methicillin-resistant Staphylococcus aureus bloodstream infections in urban Detroit.

Carol L Moore1, Paola Osaki-Kiyan, Marybeth Perri, Susan Donabedian, Nadia Z Haque, Anne Chen, Marcus J Zervos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20335422      PMCID： PMC2884493          DOI： 10.1128/JCM.00409-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  19 in total

1.  Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of National Surveillance, 1995-1999.

Authors:  Andrew E Simor; Marianna Ofner-Agostini; Elizabeth Bryce; Allison McGeer; Shirley Paton; Michael R Mulvey
Journal:  J Infect Dis       Date:  2002-08-09       Impact factor: 5.226

2.  Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility.

Authors:  Benjamin P Howden; Peter B Ward; Patrick G P Charles; Tony M Korman; Andrew Fuller; Philipp du Cros; Elizabeth A Grabsch; Sally A Roberts; Jenny Robson; Kerry Read; Narin Bak; James Hurley; Paul D R Johnson; Arthur J Morris; Barrie C Mayall; M Lindsay Grayson
Journal:  Clin Infect Dis       Date:  2004-01-29       Impact factor: 9.079

3.  Widespread dissemination in The Netherlands of the epidemic berlin methicillin-resistant Staphylococcus aureus clone with low-level resistance to oxacillin.

Authors:  W J B Wannet; E Spalburg; M E O C Heck; G N Pluister; R J L Willems; A J De Neeling
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

4.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

Authors:  K Hiramatsu; N Aritaka; H Hanaki; S Kawasaki; Y Hosoda; S Hori; Y Fukuchi; I Kobayashi
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

5.  A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides.

Authors:  Mandy Wootton; Alasdair P MacGowan; Timothy R Walsh; Robin A Howe
Journal:  J Clin Microbiol       Date:  2006-11-15       Impact factor: 5.948

6.  Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy.

Authors:  Pamela A Moise-Broder; George Sakoulas; George M Eliopoulos; Jerome J Schentag; Alan Forrest; Robert C Moellering
Journal:  Clin Infect Dis       Date:  2004-05-21       Impact factor: 9.079

7.  Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance.

Authors:  In-Gyu Bae; Jerome J Federspiel; José M Miró; Christopher W Woods; Lawrence Park; Michael J Rybak; Thomas H Rude; Suzanne Bradley; Suzana Bukovski; Cristina Garcia de la Maria; Souha S Kanj; Tony M Korman; Francesc Marco; David R Murdoch; Patrick Plesiat; Marta Rodriguez-Creixems; Porl Reinbott; Lisa Steed; Pierre Tattevin; Marie-Françoise Tripodi; Karly L Newton; G Ralph Corey; Vance G Fowler
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

8.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors:  R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

9.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit.

Authors:  Thea Chua; Carol L Moore; Mary B Perri; Susan M Donabedian; William Masch; Dora Vager; Susan L Davis; Kaitlin Lulek; Benjamin Zimnicki; Marcus J Zervos
Journal:  J Clin Microbiol       Date:  2008-05-28       Impact factor: 5.948

10.  Methicillin-resistant Staphylococcus aureus (MRSA) in hospitalized children: correlation of molecular analysis with clinical presentation and antibiotic susceptibility testing (ABST) results.

Authors:  N Abdel-Haq; H Al-Tatari; P Chearskul; H Salimnia; B I Asmar; M R Fairfax; M Amjad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-20       Impact factor: 3.267
View more
  19 in total

1.  Is vancomycin MIC "creep" method dependent? Analysis of methicillin-resistant Staphylococcus aureus susceptibility trends in blood isolates from North East Scotland from 2006 to 2010.

Authors:  B Edwards; K Milne; T Lawes; I Cook; A Robb; I M Gould
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

2.  Analysis of pathogen and host factors related to clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus.

Authors:  Nadia Z Haque; Samia Arshad; Paula Peyrani; Kimbal D Ford; Mary B Perri; Gordon Jacobsen; Katherine Reyes; Ernesto G Scerpella; Julio A Ramirez; Marcus J Zervos
Journal:  J Clin Microbiol       Date:  2012-02-15       Impact factor: 5.948

3.  Population structure of colonizing and invasive Staphylococcus aureus strains in northern Vietnam.

Authors:  Bich Ngoc Thi Vu; Alexander J Jafari; Matthew Aardema; Huong Kieu Thi Tran; Diep Ngoc Thi Nguyen; Trinh Tuyet Dao; Trung Vu Nguyen; Toan Khanh Tran; Chuc Kim Thi Nguyen; Annette Fox; Anne-Laure Bañuls; Guy Thwaites; Kinh Van Nguyen; Heiman F L Wertheim
Journal:  J Med Microbiol       Date:  2016-01-12       Impact factor: 2.472

4.  Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.

Authors:  Sanjiv M Baxi; Angelo Clemenzi-Allen; Alice Gahbauer; Daniel Deck; Brandon Imp; Eric Vittinghoff; Henry F Chambers; Sarah Doernberg
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

Review 5.  Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology.

Authors:  Sahreena Lakhundi; Kunyan Zhang
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

6.  Human cathelicidin LL-37 resistance and increased daptomycin MIC in methicillin-resistant Staphylococcus aureus strain USA600 (ST45) are associated with increased mortality in a hospital setting.

Authors:  George Sakoulas; Kripa Guram; Katherine Reyes; Victor Nizet; Marcus Zervos
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

7.  Using Whole Genome Analysis to Examine Recombination across Diverse Sequence Types of Staphylococcus aureus.

Authors:  Elizabeth M Driebe; Jason W Sahl; Chandler Roe; Jolene R Bowers; James M Schupp; John D Gillece; Erin Kelley; Lance B Price; Talima R Pearson; Crystal M Hepp; Pius M Brzoska; Craig A Cummings; Manohar R Furtado; Paal S Andersen; Marc Stegger; David M Engelthaler; Paul S Keim
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

Review 8.  The multifaceted resources and microevolution of the successful human and animal pathogen methicillin-resistant Staphylococcus aureus.

Authors:  Agnes Marie Sá Figueiredo; Fabienne Antunes Ferreira
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-04-29       Impact factor: 2.743

9.  Comparison of Multi-Drug Resistant Environmental Methicillin-Resistant Staphylococcus aureus Isolated from Recreational Beaches and High Touch Surfaces in Built Environments.

Authors:  Marilyn C Roberts; Olusegun O Soge; David No
Journal:  Front Microbiol       Date:  2013-04-04       Impact factor: 5.640

10.  Classification of epidemic community-acquired methicillin-resistant Staphylococcus aureus by anatomical site of isolation.

Authors:  Jill C Roberts
Journal:  Biomed Res Int       Date:  2014-05-05       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.